-
1
-
-
84893351700
-
Interleukin 10 receptor signaling: Master regulator of intestinal mucosal homeostasis in mice and humans
-
Shouval DS, Ouahed J, Biswas A, et al. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol 2014; 122: 177-210.
-
(2014)
Adv Immunol
, vol.122
, pp. 177-210
-
-
Shouval, D.S.1
Ouahed, J.2
Biswas, A.3
-
2
-
-
84900428511
-
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function
-
Shouval DS, Biswas A, Goettel JA, et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 2014; 40: 706-719.
-
(2014)
Immunity
, vol.40
, pp. 706-719
-
-
Shouval, D.S.1
Biswas, A.2
Goettel, J.A.3
-
3
-
-
70949087383
-
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor
-
Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-45.
-
(2009)
N Engl J Med
, vol.361
, pp. 2033-2045
-
-
Glocker, E.O.1
Kotlarz, D.2
Boztug, K.3
-
4
-
-
84864206050
-
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: Implications for diagnosis and therapy
-
Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012; 143: 347-55.
-
(2012)
Gastroenterology
, vol.143
, pp. 347-355
-
-
Kotlarz, D.1
Beier, R.2
Murugan, D.3
-
5
-
-
84875221954
-
Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation
-
Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013; 131: 825-30.
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 825-830
-
-
Engelhardt, K.R.1
Shah, N.2
Faizura-Yeop, I.3
-
6
-
-
84893812472
-
Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: A survey of the GeniusWorking Group
-
Pigneur B, Escher J, Elawad M, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the GeniusWorking Group. Inflamm Bowel Dis 2013; 19: 2820-8.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 2820-2828
-
-
Pigneur, B.1
Escher, J.2
Elawad, M.3
-
7
-
-
84891278438
-
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency
-
Neven B, Mamessier E, Bruneau J, et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood 2013; 122: 3713-3722.
-
(2013)
Blood
, vol.122
, pp. 3713-3722
-
-
Neven, B.1
Mamessier, E.2
Bruneau, J.3
-
8
-
-
83455173552
-
IL-10 elicits IFNgammadependent tumor immune surveillance
-
Mumm JB, Emmerich J, Zhang X, et al. IL-10 elicits IFNgammadependent tumor immune surveillance. Cancer cell 2011; 20: 781-96.
-
(2011)
Cancer Cell
, vol.20
, pp. 781-796
-
-
Mumm, J.B.1
Emmerich, J.2
Zhang, X.3
-
9
-
-
78651336297
-
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation
-
Kumanovics A, Perkins SL, Gilbert H, et al. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol 2010; 30: 886-93.
-
(2010)
J Clin Immunol
, vol.30
, pp. 886-893
-
-
Kumanovics, A.1
Perkins, S.L.2
Gilbert, H.3
-
10
-
-
84927722749
-
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: A meta-Analysis
-
Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-Analysis. Clin Gastroenterol Hepatol 2015; 13: 847-58.
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 847-858
-
-
Kotlyar, D.S.1
Lewis, J.D.2
Beaugerie, L.3
-
11
-
-
84893734901
-
Systematic review with metaanalysis: Malignancies with anti-tumour necrosis factor-Alpha therapy in inflammatory bowel disease
-
Williams CJ, Peyrin-Biroulet L, Ford AC. Systematic review with metaanalysis: malignancies with anti-tumour necrosis factor-Alpha therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2014; 39: 447-58.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 447-458
-
-
Williams, C.J.1
Peyrin-Biroulet, L.2
Ford, A.C.3
-
12
-
-
70449100743
-
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study
-
Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-25.
-
(2009)
Lancet
, vol.374
, pp. 1617-1625
-
-
Beaugerie, L.1
Brousse, N.2
Bouvier, A.M.3
|